Articles & Research on CoQ10
CoenzymeQ10, An Independent Predictor of Mortality in Chronic Heart Failure
Journal of the American College of Cardiology 2008
Ubiquinone As An Antioxidant
CoenzymeQ10: The Science behind the Molecule
From "Mitochondrion, Volume 7, 2007"
The Official Journal of the Mitochondria Research Society
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
by Bhagavan HN, Chopra RK
Cardiovascular Disease, Neurodegenerative Disease, Huntington's Disease, Parkinson's Disease
by Bhagavan HN, Chopra RK
The Emerging Role Of CoQ10 In Aging, Neurodegeneration, Cardiovascular Disease, Cancer And Diabetes Mellitus
by Muralikrishnan Dhanasekaran and Jun Ren
Coenzyme Q10 and Life Extension
by Emile G. Bliznakov MD
Therapeutic role of coenzyme Q10 in Parkinson's disease
by Clifford W. Shults
CARDIOVASCULAR APPLICATIONS OF COENZYME
a presentation by F.L. Rosenfeldt, S. Pepe, J.Y.Leong, A. Hadj, D.S.Esmore,S.J.Haas, H.Krum, K. Ng
The Clinical Use Of Hmg Coa-Reductase Inhibitors And The Associated Depletion Of Coenzyme Q10. A Review Of Animal And Human Publications.
by Peter H. Langsjoen and Alena M. Langsjoen
Statin Drug Crisis Looms Larger Than "Vioxx ®"
Emord & Assoc, P.C. - Press Release
Effect of Atorvastatin on Left Ventricular Diastolic Function and Ability of Coenzyme Q10 to Reverse That Dysfunction
by Marc A. Silver, MD, Peter H. Langsjoen, MD, Szabolcs Szabo, MD, Harish Patil, MD,and Allan Zelinger, MD
Are the risks of nutrient depletion by statins excessive?
by Ken Baker for Sun-Herald
Statins' problems stimulate need for better answers
by Ken Baker for Sun-Herald
THE NEW ZEALAND MEDICAL JOURNAL
Vol 117, No 1203, ISSN 1175 8716
The bioavailability of coenzyme Q10 supplements available in New Zealand differs markedly.
Coenzyme Q10 and Neoplasia: Overview of Experimental and Clinical Evidence
Emile G. Bliznakov, Raj K. Chopra, and Hemmi N. Bhagavan
Additional Q-Gel Coenzyme Q10 Products Receive Verification from USP's Verification Program for Dietary Supplements
2004-12-02 - Tishcon Corp.
Kaneka builds US plant and creates US subsidiary to meet roaring Q10 demand
29/07/2004
The rapid growth in the use of the natural antioxidant CoQ10 in the cosmetics and supplement industry has prompted the Japanese corporation Kaneka to build a new plant in the US and to establish an American subsidiary to service the production facility.
The $80 million factory - under the name Kaneka Nutrients - has been built in Pasadena, Texas, and is expected to have an initial annual production capacity of 100 metric tons by the time it is completed in the spring of 2006. Kaneka expects to expand the plant in the following years in line with projected increases in CoQ10 consumption in the US.
This decision comes after Kaneka's recent announcement that it was doubling annual production of Q10 at its Takasago, Japan, facility to 150 metric tons as of this month, at a total cost of approximately $33 million, to meet increasing worldwide demand.
The popularity of CoQ10 - a fat-soluble substance - is owed primarily to its reputation as an anti-ageing product, which works as the biosynthesis of the chemical, naturally produced by the body, begins to drop after the age of about 20. It is therefore thought to prevent damage to collagen and elastin production - stopping wrinkles.
The supplement has also been linked to protection against cancer and shown to slow the progressive deterioration associated with Parkinson's and multiple sclerosis.
Current yearly consumption of CoQ10 worldwide is estimated to be about 150 metric tons, with approximately two-thirds of this demand coming from the US, where sales of the nutrient are thought to exceed $200 million.
Other major world markets like Europe and Japan also show steady demand growth, leading to projections that worldwide demand for CoQ10 may double in the next five years.
This surge in demand and the fact CoQ10 is made through a labor-intensive fermentation process, and until recently only in Japan, has caused a shortfall in supply and soaring prices - they are currently at around $2500-3000 per kg, up from $1400 per kg last year.
Kaneka Corporation supplies between 60-70 percent of the CoQ10 sold in the US.
In addition to its availability as a supplement, the product is also found in toothpaste, skincare products and chewing gum, and Kaneka is currently developing new technologies to add it to energy bars and health beverages.
